MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

December 10, 2024

Study Completion Date

December 10, 2024

Conditions

SafetyAcceptabilityUsability

Interventions

DRUG

Placebo Vaginal Film with Square Corners

"2 x 2 placebo vaginal film with square corners"

DRUG

Placebo Vaginal Film with Rounded Corners

"2 x 2 placebo vaginal film with rounded corners"

Trial Locations (5)

Wits Reproductive Health and HIV Institute, Hillbrow

Magee-Womens Hospital, Pittsburgh

Kenya Medical Research Institute, Nairobi

The Aurum Institute, Klerksdorp

Harare Health and Research Consortium, Chitungwiza

All Listed Sponsors

collaborator

United States Agency for International Development (USAID)

FED

lead

Rohan, Lisa, PhD

OTHER

NCT06046053 - MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films | Biotech Hunter | Biotech Hunter